Literature DB >> 23116562

Mitochondrial localization of P-glycoprotein and peptide transporters in corneal epithelial cells--novel strategies for intracellular drug targeting.

Megha Barot1, Mitan R Gokulgandhi, Dhananjay Pal, Ashim K Mitra.   

Abstract

This study was designed to investigate functional localization of both efflux (P-glycoprotein, P-gp) and influx (peptide) transporters in the mitochondrial membrane of cultured rabbit primary corneal epithelial cells (rPCECs). Isolation and purification of mitochondria was performed by optimized cell fractionation method. Mitochondrial integrity was measured by JC-1 uptake experiment. The efflux activity of P-gp was assessed by performing in vitro uptake studies on isolated mitochondria with Rhodamine 123 (Rho-123) alone and in the presence of P-gp inhibitors (quinidine and cyclosporine A) using fluorimetry and flow cytometry analysis. Functional activity of peptide transporter was assessed by performing in vitro uptake studies of [3H] Gly-sar on isolated mitochondria in the presence or absence of peptide transporter substrate (Val-Val). Molecular characterization of P-gp and peptide transporter was assessed by western blot and confocal analysis. Enhanced JC-1 accumulation in the isolated fraction confirmed mitochondrial membrane integrity. Significantly higher uptake of Rho-123 on isolated mitochondria was observed in the presence of quinidine (75 and 100 μM) and cyclosporine A (10 μM). Significantly lower uptake of [3H] Gly-sar was observed in the presence of val-val due to competitive inhibition of peptide transporter on isolated mitochondria. Western blot and confocal analysis further confirmed the presence of P-gp and peptide transporter on the mitochondrial membrane of rPCECs. The present study demonstrates the functional and molecular characterization of P-gp and peptide transporters in the mitochondrial membranes of rPCECs. This knowledge of mitochondrial existence of P-gp and peptide transporter will aid in the development of subcellular ocular drug delivery strategies.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23116562      PMCID: PMC3545686          DOI: 10.1016/j.exer.2012.10.006

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  36 in total

Review 1.  Multidrug resistance in cancer: role of ATP-dependent transporters.

Authors:  Michael M Gottesman; Tito Fojo; Susan E Bates
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

Review 2.  Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration.

Authors:  Fong-Qi Liang; Bernard F Godley
Journal:  Exp Eye Res       Date:  2003-04       Impact factor: 3.467

Review 3.  Current prodrug strategies via membrane transporters/receptors.

Authors:  Banmeet S Anand; Surajit Dey; Ashim K Mitra
Journal:  Expert Opin Biol Ther       Date:  2002-08       Impact factor: 4.388

Review 4.  Mechanisms of cancer drug resistance.

Authors:  Michael M Gottesman
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

5.  Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells.

Authors:  S Meschini; A Calcabrini; E Monti; D Del Bufalo; A Stringaro; E Dolfini; G Arancia
Journal:  Int J Cancer       Date:  2000-09-01       Impact factor: 7.396

6.  Functional intracellular P-glycoprotein.

Authors:  A B Shapiro; K Fox; P Lee; Y D Yang; V Ling
Journal:  Int J Cancer       Date:  1998-06-10       Impact factor: 7.396

7.  Subcellular localization and activity of multidrug resistance proteins.

Authors:  Asha Rajagopal; Sanford M Simon
Journal:  Mol Biol Cell       Date:  2003-04-17       Impact factor: 4.138

8.  Molecular evidence and functional expression of P-glycoprotein (MDR1) in human and rabbit cornea and corneal epithelial cell lines.

Authors:  Surajit Dey; Jignesh Patel; Banmeet S Anand; Blisse Jain-Vakkalagadda; Preetham Kaliki; Dhananjay Pal; Vadivel Ganapathy; Ashim K Mitra
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-07       Impact factor: 4.799

Review 9.  Lipids as a target for drugs modulating multidrug resistance of cancer cells.

Authors:  A B Hendrich; K Michalak
Journal:  Curr Drug Targets       Date:  2003-01       Impact factor: 3.465

10.  PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine.

Authors:  M Buyse; F Berlioz; S Guilmeau; A Tsocas; T Voisin; G Péranzi; D Merlin; M Laburthe; M J Lewin; C Rozé; A Bado
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

View more
  6 in total

1.  Mitochondrial expression and activity of P-glycoprotein under oxidative stress in outer blood-retinal barrier.

Authors:  Yue-Hong Zhang; Juan Li; Wei-Zhong Yang; Zhuan-Hua Xian; Qi-Ting Feng; Xiang-Cai Ruan
Journal:  Int J Ophthalmol       Date:  2017-07-18       Impact factor: 1.779

Review 2.  Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition.

Authors:  Mariko Nakano; Catherine M Lockhart; Edward J Kelly; Allan E Rettie
Journal:  Drug Metab Rev       Date:  2014-05-26       Impact factor: 4.518

3.  Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway.

Authors:  Lin Yang; Chengda Zhang; Jiaoting Chen; Sheng Zhang; Guixuan Pan; Yanfei Xin; Lin Lin; Zhenqiang You
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

4.  Artificial Protein Coronas Enable Controlled Interaction with Corneal Epithelial Cells: New Opportunities for Ocular Drug Delivery.

Authors:  Carlo Astarita; Sara Palchetti; Mina Massaro-Giordano; Marina Di Domenico; Francesco Petrillo; Silvia Boffo; Giulio Caracciolo; Antonio Giordano
Journal:  Pharmaceutics       Date:  2021-06-12       Impact factor: 6.321

5.  Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes.

Authors:  Menghao Shi; Jiulong Zhang; Xiaowei Li; Shuang Pan; Jie Li; Chunrong Yang; Haiyang Hu; Mingxi Qiao; Dawei Chen; Xiuli Zhao
Journal:  Int J Nanomedicine       Date:  2018-07-18

6.  Fluorescent Silica Nanoparticles Targeting Mitochondria: Trafficking in Myeloid Cells and Application as Doxorubicin Delivery System in Breast Cancer Cells.

Authors:  Federica Sola; Mariele Montanari; Mara Fiorani; Chiara Barattini; Caterina Ciacci; Sabrina Burattini; Daniele Lopez; Alfredo Ventola; Loris Zamai; Claudio Ortolani; Stefano Papa; Barbara Canonico
Journal:  Int J Mol Sci       Date:  2022-03-12       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.